Medicalizing Menopause: Interventions & Impacts

In recent decades, menopause has increasingly been framed as a medical condition rather than as a natural life transition. Menopause is a biological transition that marks the end of a woman’s reproductive years, resulting from the natural decline of ovarian function. While medical interventions can provide relief, their widespread use raises concerns about overmedicalization—treating a natural process as a disease in ways that may not always be necessary or beneficial. Overmedicalization can undermine bodily autonomy, limit alternative approaches to menopause care, and expose women to potential health risks that are associated with unnecessary treatments. This shift has significant ethical implications, particularly as pharmaceutical companies promote hormone therapy and other treatments as default solutions for managing menopause symptoms. By exploring the historical context behind treatments for menopause, the influence of medical narratives on societal perceptions of aging, and the perspectives of various cultures, the public, and women experiencing menopause, this paper will assess the ethical tension between autonomy and the medical model, arguing that overmedicalization undermines the ability for women to make informed choices, limits alternative approaches, and potentially exposes them to unnecessary risks.

Background information

Menopause 

The process of menopause occurs over three distinct stages, each characterized by unique hormonal and physiological changes. Understanding these stages provides insight into the complexity of the process and its impact on a woman’s health. The stages include the reproductive stage, perimenopause (early and late stages), and menopause. During the reproductive stage, regular menstrual cycles occur as part of normal ovarian function. This generally occurs from puberty to the onset of menopause, ending between ages 45–55. As women age, they transition into perimenopause, a phase marked by fluctuating hormone levels and irregular menstrual cycles. This is further divided into two stages: the early stage, where menstrual cycles begin to vary by more than seven days, showing the initial disruption in hormonal regulation, and the late stage, where cycles become more erratic, with some women experiencing gaps of 42 days or more between periods (Taffe and Dennerstein, 398). The fluctuation of hormone levels is often accompanied by occasional hot flashes, night sweats, breast tenderness, and subtle mood swings. Fertility declines, and some women notice increased irritability or anxiety. These variants indicate significant hormonal shifts that lead up to menopause (World Health Organization 10). 

Menopause itself is clinically defined as the point when a woman has not had a menstrual period for 12 consecutive months (World Health Organization 8). This criteria is commonly used in medical studies to determine when menopause has officially occurred. Hot flashes and night sweats become more persistent, which can disrupt sleep and day-to-day life (World Health Organization 23). Estrogen decline leads to increased risk of urinary tract infections and changes in fat distribution, which can contribute to weight gain and joint pain (Pinn 17). Many women experience cognitive changes as well, such as brain fog or difficulty concentrating. Women then enter postmenopause, which extends from menopause through the remainder of life. The early postmenopausal stage is characterized by the absence of menstruation as the body continues to adjust to lower hormone levels, while the late postmenopausal stage is marked by the stabilization of ovarian hormone production at a permanently reduced level (World Health Organization 11). Each of these stages brings distinct physiological and symptomatic experiences, which can vary depending on the person. 

Symptoms and Treatments

According to the U.S. Agency for Healthcare Research and Quality (AHRQ), 85 percent of women experience some symptoms during menopause, though the severity and type of symptoms vary widely. A smaller subset, around 20 to 25 percent, report experiencing severe symptoms that significantly interfere with daily functioning (Grant et al). Modern menopause treatments range from pharmaceutical interventions to lifestyle modifications, depending on symptom severity and personal preferences. The most commonly prescribed option is hormone replacement therapy (HRT), which involves supplementing estrogen—sometimes in combination with progesterone, known as combined HRT—to help manage symptoms. 

These symptoms often include vasomotor disturbances such as hot flashes and night sweats, which can severely disrupt sleep, contributing to fatigue and mood changes (World Health Organization 25). Other symptoms like vaginal dryness and bone loss can lead to discomfort, pain during intercourse, and increased risk of infection, all of which impact quality of life. A New Zealand study assessing the impact of combined HRT on quality of life found that roughly 75 percent of women experiencing hot flushes and night sweats had complete relief after one year (Welton et al.). Similarly, the AHRQ’s study showed that for women with severe menopausal symptoms, HRT improved their quality-adjusted life year weight by 50 percent (Grant et al.). These findings highlight the potential benefits of HRT for women with intense symptoms, particularly in the short term.

While HRT has proven effective in reducing discomfort and improving quality of life, it increases the risk of certain illnesses, especially with long-term use. Women who are unable or unwilling to take HRT may have access to non-hormonal medical treatments as another option. Although they are not widely marketed, non-pharmaceutical approaches are also available to manage menopause. Dietary adjustments may provide mild relief of certain symptoms. For example, adequate calcium and vitamin D intake helps to prevent bone loss. Regular exercise supports bone health and improves overall well-being, while cognitive behavioral therapy can help alleviate stress, mood changes, and sleep disturbances. While menopause is a natural and inevitable process, the way it is understood and managed has been shaped by both medical and cultural narratives, influencing the choices available to women during this transition.

Menopause in the Medical Field

The World Health Organization defines menopause as the “permanent cessation of menstruation resulting from loss of ovarian follicular activity” (World Health Organization 7). This classification frames menopause as a biological endpoint rather than a pathological state. However, medical discourse has historically fluctuated between treating menopause as a natural life stage and as a deficiency requiring medical intervention. This shifting perspective has had significant implications for how menopause is managed and understood. Healthcare providers, especially general practitioners and gynecologists, are key figures here. As the holders of medical knowledge and treatment access, when treating their patients they hold ethical responsibilities rooted in the principles of beneficence and non-maleficence: to do good, and to do no harm. However, these values can become complicated when clinical norms reflect societal biases. Women’s health historian Sandra Coney notes, “The midlife woman is a prime target for the new prevention-oriented general practice” (Coney 18). This illustrates how the healthcare system may unintentionally steer patients toward a model of intervention, even when symptoms are mild or transient. Providers may feel pressure to offer treatments not solely based on patient need, but also on clinical guidelines shaped by pharmaceutical influence or systemic bias. Even though they act in good faith with the aim to do no harm, their reliance on standardized medical solutions may constrain women’s autonomy. The ethical dilemma here is not in the desire to relieve symptoms, but in the potential harm done by reinforcing a one-size-fits-all approach that disregards diverse experiences of menopause. 

Historically, menopause has often been referred to as a form of hormonal deficiency, similar to a disease state, which has justified various medical treatments and interventions (Singh et al., 7). This perspective aligns with broader medical trends that pathologize bodily changes associated with aging, positioning menopause as a condition in need of correction rather than a normal biological process. However, this framing raises ethical concerns regarding autonomy, where we must consider how much choice women truly have in viewing menopause as a medical issue versus a natural transition. If medical narratives overwhelmingly depict menopause as a disorder requiring treatment, women may be influenced to seek medical interventions they might not otherwise consider necessary. Their perceptions of menopause, and their decisions about whether to pursue treatment, may be shaped more by societal and medical expectations than by their personal experiences. Medical humanities author Frederik Kaufman’s assertion that “if the concept of a disease is partly evaluative, then a condition cannot be a disease unless we disvalue it” underscores how medical and social attitudes shape our understanding of menopause (271).  In other words, menopause is not inherently a medical problem—it becomes one when society and the medical community label it as one. The disvaluation of menopause reflects broader social anxieties around aging and femininity, and reinforces the idea that a post-reproductive body is one in decline. 

Medicalization

Medicalization is the process by which human conditions, behaviors, or experiences are defined and treated as medical issues, often requiring diagnosis, intervention, or treatment by healthcare professionals (Last 213). While medicalization can be beneficial when it provides treatment for genuine medical conditions, it becomes problematic when it pathologizes behaviors and processes that may be in the range of normal human experiences. One clear example of this is the increasing medicalization of childhood behaviors, particularly through the diagnosis and treatment of Attention-Deficit/Hyperactivity Disorder (also known as ADHD). While ADHD is a legitimate condition for some children, its rising rates of diagnosis and increased prescription of pharmaceutical medications have raised concerns about whether the medicalization of childhood energy, inattention, or impulsivity is always justified (Kazda). In many cases, behaviors that might once have been seen as natural variations in personality, learning styles, or responses to environmental factors (lack of physical activity, rigid school structures, high academic pressures, etc) are now treated as medical disorders requiring pharmaceutical intervention. This increase in diagnoses reinforces the idea that children who struggle in traditional settings are "disordered" and also places the responsibility for change on the child individually, instead of social or educational reforms. Additionally, it creates a dependency on medication rather than exploring alternative approaches such as behavioral therapy, changes in learning environments, or lifestyle adjustments. By transforming normal childhood behaviors into medical conditions, the medicalization of normal childlike behavior raises important questions about whether we are genuinely helping all children diagnosed or unnecessarily turning natural differences into medical problems that require treatment.

As Kaufman argues, “Pathology is understood with respect to the abnormal, a kind of departure from normal” (277). His assertion suggests that a condition is only classified as a disease when it is perceived as undesirable or diverging from an accepted standard of health. Applying this to menopause, the medical community has reinforced the idea that the process is something to be corrected. This medicalization does not stem from any dysfunction in menopause itself but from societal values that disvalue aging and post-reproductive bodies. In the early 20th century, doctors commonly referred to menopause as a “deficiency disease” caused by the loss of ovarian function, recommending estrogen therapy to restore youthfulness and femininity (Reid). This medicalization does not stem from any dysfunction in menopause itself but from societal values that disvalue aging and post-reproductive bodies. By presenting menopause as a problem in need of medical intervention, this framework influenced how individuals perceive their own experiences, potentially leading them to seek treatments based more on external expectations than personal necessity. 

Pharmaceutical companies are deeply intertwined in this reframing of menopause. Their role extends beyond offering treatments—they help construct the very narrative that menopause is a medical problem in need of fixing. Sandra Coney emphasizes that “it must be stressed that the subject of all this attention is well women” (20), a statement that underscores how menopause, though a natural and expected life stage, has been repositioned as a health condition for a market of otherwise healthy individuals. Women experiencing menopause, the primary stakeholders in this debate, are often placed at a crossroads. While treatments can offer relief, the influence of medical narratives may obscure genuine choice between medical and non-medical options. Coney argues that “Modern medicine claims that it provides the midlife woman not with dilemmas but with ‘choices’” (21). The “choices” being offered are often constrained by a framework that already defines menopause as a deficiency to be managed or corrected.

A key ethical tension in the medicalization of menopause lies between autonomy and the medical model. Rather than empowering women with true autonomy, the medical model frequently masks a predetermined path—suggesting that to be responsible, modern, or healthy, a woman should pursue intervention. For example, in a study on the use of HRT, while many women report symptom relief, others report feeling that their decisions are guided by societal expectations rather than personal preference (Sievert). In this way, what is presented as a neutral or empowering set of options can actually reflect societal discomfort with aging, femininity, and non-reproductive bodies. The dilemma Coney refers to lies in the fact that, while women are technically free to accept or refuse treatment, their decisions are made within a cultural and medical landscape that heavily implies one “correct” answer. Because of this, the idea of “choice” becomes ethically complicated, especially when there is tension between beneficence and autonomy. This tension emerges when physicians, operating under the principle of beneficence—the duty to promote a patient's well-being—recommend treatments they believe to be beneficial, such as hormone replacement therapy. Yet these recommendations are often shaped by generalized medical assumptions about aging and womanhood, rather than individualized assessments of each patient’s needs. In doing so, beneficence can inadvertently pressure women toward certain decisions, making it difficult to exercise true autonomy. What appears as a neutral or helpful suggestion may subtly signal that non-intervention is irresponsible or irrational, thereby constraining the space for genuine, self-directed choice. The framing of menopause as a medical issue inherently influences how women perceive their own experiences. This influence may lead them toward predefined solutions driven by medical narratives that don’t prioritize  women’s personal health needs.

Social and Cultural Views

Menopause is best understood as a natural life stage rather than a medical condition—a view supported by cross-cultural research and ethical considerations alike. In cultures that embrace menopause as a normal and even empowering transition, women report fewer distressing symptoms, suggesting that the experience is shaped not only by biology but also by cultural attitudes and expectations (Kaufert and Lock). These cross-cultural differences reveal that menopause is not inherently pathological but rather a complex and deeply human process that reflects the values and assumptions of the society in which it occurs.

Anthropologist Margaret Lock’s comparative research found that Japanese women report fewer and less severe menopausal symptoms than their Western counterparts (Lock). In Japan, menopause, referred to as konenki, is typically seen as a natural life phase associated with aging, wisdom, and shifting social roles. This positive framing reduces stigma and fosters acceptance, which in turn may diminish physical distress. Lock suggests that cultural attitudes toward aging, especially the lack of an idealized youth standard, play a key role in shaping how menopause is experienced. When women are encouraged to see menopause as a meaningful transition rather than a medical failure, they are more likely to cope well and less likely to suffer anxiety or shame.

Other non-Western cultures reinforce this naturalistic and affirming view. Among some Native American tribes, postmenopausal women are revered as spiritual leaders and keepers of wisdom (Beyene). Here, menopause is not viewed as a loss but as a transition into a respected and influential role. Similarly, in Sotho communities of southern Africa, postmenopausal women gain access to cultural and religious roles previously restricted to men (Flint), symbolizing increased authority and respect. In many parts of India, menopause marks a shift from reproductive responsibilities to a more spiritually centered life, with Hindu traditions sometimes granting postmenopausal women greater religious freedom, as they are no longer subject to menstrual-related restrictions (Famila). These traditions frame menopause not as a clinical event, but as a natural and even liberating stage in a woman’s life.

By contrast, Western societies often approach menopause through a biomedical lens that treats it as a condition to be diagnosed and managed. Emphasis is placed on symptoms, such as hot flashes, mood swings, and estrogen decline, and their treatment, typically through hormone replacement therapy (Chrisler). This medicalized model reflects broader cultural discomfort with aging and tends to portray menopause as a deficiency or problem. Women in Western cultures may experience heightened anxiety, stigma, and pressure to undergo treatments in order to “fix” something that is, in fact, a normal part of life.

This contrast reveals two competing frameworks: one that honors menopause as a natural life stage and another that pathologizes it as a medical condition. The ethical implications are significant. When public health systems promote only the biomedical model, they risk violating the principle of non-maleficence, which is doing harm by fostering fear, shame, and unnecessary medical intervention. Conversely, a model that acknowledges menopause as a natural process upholds autonomy, cultural competence, and holistic well-being.

University of Massachusetts anthropology professor Lynette Sievert notes in her biocultural study of menopause that “many women in the United States disdain the fuss made about menopause in the popular press” (xiii), underscoring a disconnect between dominant medical narratives and women's lived experiences. Reframing menopause as a natural transition not only aligns more closely with how many women across the world experience it, while also supporting a more ethical, inclusive, and empowering approach to women's health.

Beneficence and Non-Maleficence

The ethical principles of beneficence and nonmaleficence are central to evaluating the medicalization of menopause. While HRT offers substantial benefits to women suffering from severe symptoms, it also carries significant risks, such as an increased likelihood of breast cancer, heart disease, and blood clots. For example, the Women’s Health Initiative found a 25 percent increased risk of breast cancer for women taking combined HRT during menopause (Chlebowski et al.). Similarly, researchers at Oxford University found a 37 percent increased risk of ovarian cancer for women taking hormone replacement therapy during menopause (Collaborative Group on Epidemiological Studies of Ovarian Cancer). These risks raise questions about whether the benefits truly outweigh the harms, especially considering that menopause is a natural life stage rather than a medical condition. Even though all medical treatments come with inherent risks, the ethical challenge lies in determining when the intervention is truly necessary. Because menopause is not a disease but a biological transition, the decision to use HRT should be carefully weighed against its potential harms, ensuring that the treatment aligns with the individual’s health needs and personal preferences. The decision to use HRT should always be personalized and carefully considered, taking into account both the benefits and risks. Women should be given the freedom to choose treatment options that best align with their health needs and preferences.

Conclusion

The ethical considerations surrounding menopause highlight the ongoing tension between medicalization and the autonomy of women in healthcare decision-making. Menopause, as a natural biological process, has often been treated as a medical condition requiring intervention, primarily through hormone replacement therapy (HRT) and other medical treatments. This framing potentially undermines women’s agency by not fully empowering them with all available information or alternative approaches. The medicalization of menopause raises ethical questions about patient autonomy, the pressures of societal expectations, and the potential harms of over-medicalizing a natural process. At the heart of these discussions is the importance of informed consent. Women deserve to be fully educated about the risks, benefits, and alternatives to medical treatments, including HRT. Empowering women to make their own decisions about their healthcare, without societal or medical pressure to conform, is essential to advancing ethical practices in menopause care.

Proposed Solutions/Approaches:

It is crucial for healthcare providers to ensure that all women going through menopause are fully informed about their treatment options. This means presenting not only medical treatments like HRT but also non-medical approaches such as lifestyle changes, exercise, and mental health support. Informed consent should be more than just signing a form—it should be an ongoing, educational conversation about all available options, tailored to each woman's needs and preferences. Healthcare providers should continue to offer a range of treatment options for menopause, ensuring women are educated about the risks and benefits of each. This empowers women to make the choice that best aligns with their values and health goals.

Menopause is often surrounded by stigma, and women may not fully understand what to expect during this stage of life. Public health campaigns should aim to destigmatize menopause and increase awareness about both medical and non-medical treatment options. Education on menopause should extend beyond healthcare providers to the general public, helping society view it as a natural life transition rather than a medical problem. Public campaigns should educate women and healthcare providers about menopause as a natural part of life, portraying a range of solutions beyond pharmaceuticals, such as diet, exercise, and mental health approaches.

Healthcare providers should adopt a culturally sensitive approach to menopause care, understanding that menopause is experienced differently across cultures. The healthcare system should be adaptable to women’s cultural beliefs and values, providing care that is respectful of diverse backgrounds. Menopause care should take into account the unique cultural beliefs about aging and health that influence women’s experiences of menopause. Culturally relevant treatment options should be made available to ensure women’s health choices are respected.

The extent to which healthcare systems should point women toward non-medical menopause options must go beyond optional pamphlets or surface-level mentions during appointments. Non-medical approaches should be fully integrated into the standard of care, not treated as alternative or secondary. This means building interdisciplinary care models where nutritionists, mental health professionals, and fitness experts work alongside physicians, especially in clinics serving women in midlife. It also means investing in provider training so that clinicians are equipped to discuss the full range of evidence-based treatments with equal weight. While doctors play a key role in presenting options, institutions like hospitals, public health agencies, and medical schools should include this broader understanding of menopause into healthcare policy, education, and infrastructure. Without systemic commitment, non-medical options will be undervalued, leaving many women with an incomplete picture of their choices.

To foster better healthcare decision-making, healthcare providers must create environments where women feel comfortable discussing their menopausal symptoms and exploring treatment options. Achieving this requires more than just empathy at the individual level. This calls for systemic change, including training providers to recognize and address their own assumptions about aging, gender, and menopause. When healthcare environments are truly open and supportive, women are better able to make informed decisions that reflect their values, free from external pressures or stigma. This enables women to make decisions about their health without external pressure.

Broader Questions/Thoughts:

The way menopause is viewed is heavily influenced by societal pressures and gender norms. Menopause is often stigmatized, framed as something that needs to be fixed or hidden, which can lead to women feeling pressured into medical treatments they may not want. This raises broader questions about the influence of societal norms in shaping medical practices and healthcare choices. How much responsibility should society take in promoting certain health practices, and how much should individuals be free to decide for themselves? How can we ensure that healthcare choices, such as menopause treatment, are free from the pressure of societal expectations? Should the healthcare system reflect these pressures, or should it foster autonomy and diversity in care? 

Menopause is not an isolated case of medicalization. The way other stages of life, such as, have been medicalized raises similar ethical concerns. When do we cross the line between offering healthcare and imposing treatments that may not be necessary or wanted? In this context, we must ask whether we should embrace other approaches to menopause or continue with medical solutions that may not always be in the best interest of individuals. How do we ensure that we don’t overstep?

Menopause is experienced differently across the world. Exploring how various cultures and healthcare systems approach menopause could provide valuable insights into how to better support women’s health globally. A comparison could reveal best practices that could be adopted by other countries, enhancing the healthcare experience for women everywhere. Healthcare practitioners and other stakeholders should look at how different countries and cultures approach menopause, especially in places where it is seen as a natural transition rather than a medical issue, and explore if and how these perspectives can inform better practices globally.

Menopause is not just a biological transition, it is a cultural and philosophical one as well. To treat it purely through the lens of medical intervention is to miss the opportunity to reimagine how we approach women's health more broadly. The real ethical challenge lies not in deciding whether to treat symptoms, but in interrogating why certain bodies and experiences are framed as problems in the first place. What if the discomfort around menopause lies not within the body, but in a culture that struggles to value women beyond reproduction, that equates youth with worth, and that medicalizes deviation from narrow norms? These questions push us beyond individual choice and into the systemic, asking us to reconsider how power, profit, and societal narratives shape the very definitions of health and illness. To foster truly ethical care, then menopause must not be understood as a failure of the body, but instead as an invitation to reexamine which perspectives shape medical knowledge, what stories we believe about aging, and how we can expand the concept of care to further support patients moving into older age. The path forward requires not just more choices, but better frameworks for understanding them. The most ethical approach to menopause care is not to fix what isn’t broken, but to listen more closely to the women living it, and to let their experiences redefine what health means.

Works Cited

Beyene, Yewoubdar. From Menarche to Menopause: Reproductive Lives of Peasant Women in Two Cultures. SUNY Press, 1989.

Chlebowski, Rowan T., et al. "Estrogen plus Progestin and Breast Cancer Incidence and

Mortality in the Women's Health Initiative Observational Study." JNCI: Journal of the

National Cancer Institute, vol. 105, no. 8, 8 Apr. 2013, pp. 526-35. PubMed,

https://doi.org/10.1093/jnci/djt043.

Chrisler, Joan C. "Gendered Narratives of Aging and the Menopausal Transition." Feminism & Psychology, vol. 18, no. 4, 2008, pp. 401-406.

Collaborative Group on Epidemiological Studies of Ovarian Cancer. "Menopausal Hormone Use and Ovarian Cancer Risk: Individual Participant Meta-analysis of 52 Epidemiological Studies." The Lancet, vol. 385, no. 9980, May 2015, pp. 1835-42, https://doi.org/10.1016/s0140-6736(14)61687-1.

Coney, Sandra. The Menopause Industry : How the Medical Establishment Exploits Women.

Hunter House, 1994.

Famila, Nupur. "Menopause in Urban and Rural India: A Comparative Perspective." Indian

Journal of Social Sciences, vol. 15, no. 2, 2017, pp. 65-80.

Flint, Margaret. "Menopause and Social Status in Southern Africa." Anthropology & Aging

Quarterly, vol. 27, no. 1, 2006, pp. 12-18.

Grant, Mark et al. Menopausal Symptoms: Comparative Effectiveness of Therapies [Internet].

Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Mar. (Comparative Effectiveness Reviews, No. 147.) Available from: https://www.ncbi.nlm.nih.gov/books/NBK285463/

Kaufert, Patricia, and Margaret Lock. "Medicalization of Women's Third Age: Lessons from

Japan." Social Science & Medicine, vol. 42, no. 1, 1996, pp. 103-110.

Kazda, Luise et al. "Overdiagnosis of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Systematic Scoping Review." JAMA network open vol. 4,4 e215335. 1

Apr. 2021, doi:10.1001/jamanetworkopen.2021.5335

Last, John M. A Dictionary of Public Health. Oxford UP, 2007.

Lock, Margaret. Encounters with Aging: Mythologies of Menopause in Japan and North

America. University of California Press, 1993.

Lock, Margaret. "Ambiquities of Aging: Japanese Experience and Perceptions of Menopause." Culture, Medicine and Psychiatry, vol. 10, no. 1, Mar. 1986, pp. 23-46,

https://doi.org/10.1007/bf00053261.

Pinn, Vivian. Our Bodies, Ourselves : Menopause. Simon & Schuster, 2006.

Reid, Robert L. "Menopause Medicine: Past, Present, and Future." Journal of Obstetrics and

Gynaecology Canada, vol. 41, Dec. 2019, pp. S347-S349, https://doi.org/10.1016/j.jogc.2019.08.026.

Sievert, Lynnette Leidy. Menopause : a Biocultural Perspective. Rutgers UP, 2006.

Singh, Amarjeet et al. "A historical perspective on menopause and menopausal age." Bulletin of the Indian Institute of History of Medicine (Hyderabad) vol. 32,2 (2002): 121-35.

Welton, A. J., et al. "Health Related Quality of Life after Combined Hormone Replacement

Therapy: Randomised Controlled Trial." BMJ, vol. 337, nos. aug21 2, 21 Aug. 2008, p.

a1190, https://doi.org/10.1136/bmj.a1190.

World Health Organization. Research on the Menopause : Report of a WHO Scientific Group. World Health Organization ; WHO Publications Centre USA [distributor], 1981. World

Health Organization.